These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15638894)

  • 1. Prostate cancer: socio-economic, geographical and private-health insurance effects on care and survival.
    Hall SE; Holman CD; Wisniewski ZS; Semmens J
    BJU Int; 2005 Jan; 95(1):51-8. PubMed ID: 15638894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of socio-economic and locational disadvantage on survival after a diagnosis of lung or breast cancer in Western Australia.
    Hall S; Holman CD; Sheiner H; Hendrie D
    J Health Serv Res Policy; 2004 Oct; 9 Suppl 2():10-6. PubMed ID: 15511320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer surgical care and survival: do private health insurance, socioeconomic and locational status make a difference?
    Hall SE; Holman CD; Platell C; Sheiner H; Threlfall T; Semmens J
    ANZ J Surg; 2005 Nov; 75(11):929-35. PubMed ID: 16336380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of surgical care for prostate cancer in NSW, 1993-2002: rural/urban and socio-economic variation.
    Hayen A; Smith DP; Patel MI; O'Connell DL
    Aust N Z J Public Health; 2008 Oct; 32(5):417-20. PubMed ID: 18959543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
    Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.
    Gallina A; Karakiewicz PI; Chun FK; Briganti A; Graefen M; Montorsi F; Walz J; Jeldres C; Erbersdobler A; Salonia A; Suardi N; Dehò F; Schlomm T; Scattoni V; Haese A; Heinzer H; Valiquette L; Rigatti P; Huland H
    BJU Int; 2007 Jun; 99(6):1404-8. PubMed ID: 17428250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unequal access to breast-conserving surgery in Western Australia 1982-2000.
    Hall SE; Holman CD; Hendrie DV; Spilsbury K
    ANZ J Surg; 2004 Jun; 74(6):413-9. PubMed ID: 15191470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.
    Jayadevappa R; Chhatre S; Whittington R; Bloom BS; Wein AJ; Malkowicz SB
    BJU Int; 2006 May; 97(5):955-62. PubMed ID: 16643477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and capsular incision at the time of open retropubic radical prostatectomy.
    Freedland SJ; Grubb KA; Yiu SK; Nielsen ME; Mangold LA; Isaacs WB; Epstein JI; Partin AW
    J Urol; 2005 Nov; 174(5):1798-801; discussion 1801. PubMed ID: 16217290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors.
    D'Amico AV; Chen MH; Catalona WJ; Sun L; Roehl KA; Moul JW
    Cancer; 2007 Jul; 110(1):56-61. PubMed ID: 17530618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in surgeon volume and use of pelvic lymph node dissection with open and minimally invasive radical prostatectomy.
    Prasad SM; Keating NL; Wang Q; Pashos CL; Lipsitz S; Richie JP; Hu JC
    Urology; 2008 Sep; 72(3):647-52; discussion 652-3. PubMed ID: 18649928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.
    Jeldres C; Suardi N; Walz J; Saad F; Hutterer GC; Bhojani N; Shariat SF; Perrotte P; Graefen M; Montorsi F; Karakiewicz PI
    Eur Urol; 2008 Jul; 54(1):107-16. PubMed ID: 17996358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer treatment for economically disadvantaged men: a comparison of county hospitals and private providers.
    Parsons JK; Kwan L; Connor SE; Miller DC; Litwin MS
    Cancer; 2010 Mar; 116(5):1378-84. PubMed ID: 20101733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical prostatectomy for clinical T4 prostate cancer.
    Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
    Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possession of health insurance in Australia--how does it affect hospital use and outcomes?
    Brameld K; Holman D; Moorin R
    J Health Serv Res Policy; 2006 Apr; 11(2):94-100. PubMed ID: 16608584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does federal health care policy influence switching between the public and private sectors in individuals?
    Moorin RE; D'Arcy J Holman C
    Health Policy; 2006 Dec; 79(2-3):284-95. PubMed ID: 16510206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.
    Bastian PJ; Gonzalgo ML; Aronson WJ; Terris MK; Kane CJ; Amling CL; Presti JC; Mangold LA; Humphreys E; Epstein JI; Partin AW; Freedland SJ
    Cancer; 2006 Sep; 107(6):1265-72. PubMed ID: 16900523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling changes in the determinants of PHI utilisation in Western Australia across five health care policy eras between 1981 and 2001.
    Moorin RE; Holman CD
    Health Policy; 2007 May; 81(2-3):183-94. PubMed ID: 16831484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.